Bolak Co

Bolak Co EBIT per Share

The EBIT per Share of Bolak Co (002760.KS) as of Oct 28, 2026 is 37.23 KRW. In the previous year, EBIT per Share was -29.91 KRW — a change of -224.46% (higher).

EBIT per Share

37.23KRW

YoY

-224.46%

Last updated:

EBIT per Share of Bolak Co is 2025 37.23 KRW. EBIT per Share of Bolak Co was 2024 -29.91 KRW. It decreases by -224.46% higher compared to the previous year.

The Bolak Co EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2018
22.07 KRW
Jan 1, 2019
11.53 KRW
Jan 1, 2020
5.78 KRW
Jan 1, 2021
31.80 KRW
Jan 1, 2022
57.25 KRW
Jan 1, 2023
13.10 KRW
Jan 1, 2024
-29.91 KRW
Jan 1, 2025
37.23 KRW
The Bolak Co EBIT per Share history
YEAREBIT per ShareYoY
37.23KRW-224.46%
-29.91KRW-328.39%
13.10KRW-77.12%
57.25KRW+80.04%
31.80KRW+449.71%
5.78KRW-49.83%
11.53KRW-47.76%
22.07KRW+3.35%
21.35KRW-37.03%
33.91KRW+58.75%
21.36KRW-37.41%
34.13KRW+385.85%
7.03KRW-76.37%
29.73KRW+974.70%
2.77KRW-77.60%
12.35KRW+150.40%
4.93KRW+236.55%
1.47KRW-107.11%
-20.60KRW-596.61%
4.15KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bolak Co Stock analysis

What does Bolak Co do? Bolak Co., Ltd. generates revenue through its two core business divisions: food additives and pharmaceutical ingredients. The food additives division produces flavors, colors, botanical extracts, nutraceuticals, white emulsion, antioxidants, emulsifiers, bleaching agents, acidulant, and sweetness products. The pharmaceutical ingredients division manufactures extract powers, fluid extracts, tinctures, protein concentrates, and calcium carboxymethyl cellulose (CMC). Domestic and overseas markets purchase these products, with the company distributing them across both regions. The firm's product portfolio targets food manufacturers and pharmaceutical companies seeking raw materials for their production processes. Bolak Co., Ltd. serves food manufacturers and pharmaceutical companies as its primary customer segments. These segments require specialized ingredients for their product development and production lines. The company's domestic market includes Korean food and pharma firms, while overseas buyers include international food processors and pharmaceutical producers. The firm's product range supports both the food and pharmaceutical industries through direct sales to these end-users. The company's revenue streams are derived from the sale of its manufactured ingredients, with no mention of additional services or licensing. Food additives like white emulsion and antioxidants are sold to food producers, while pharmaceutical ingredients such as protein concentrates and CMC are supplied to drug manufacturers. The business model relies on consistent demand for these raw materials from established industry clients. Bolak Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bolak Co stock

EBIT per Share of Bolak Co is 37.23 KRW in 2025.

EBIT per Share of Bolak Co changed from -29.91 KRW to 37.23 KRW, representing a -224.46% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Bolak Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Bolak Co

All Key Metrics — Bolak Co